Short version of this FIT Stack review: the bundle pairs CJC-1295 without DAC and ipamorelin, which is the most sensible combination in the growth hormone secretagogue category because the two compounds hit different receptors and release more growth hormone together than separately. What a FIT Stack review cannot honestly tell you is what that extra growth hormone does to body composition, because those trials have not been run.
That distinction is the whole point of the page. The pharmacology is solid. The outcome claims that usually surround it are not.
What Is in the FIT Stack
Two vials of lyophilised powder, sold as a bundle rather than a pre-mixed product:
- CJC-1295 no DAC, 5 mg. A modified 29 amino acid analogue of growth hormone releasing hormone. It binds the GHRH receptor on pituitary cells and raises the signal to produce and release growth hormone. Without the drug affinity complex it clears in roughly half an hour, so each dose is a discrete pulse rather than a plateau.
- Ipamorelin, 5 mg. A five amino acid ghrelin receptor agonist. It triggers a rapid growth hormone pulse, and unlike GHRP-2 and GHRP-6 it does not measurably move cortisol or prolactin at the doses studied.
Neither is reconstituted. Bacteriostatic water is bought separately, and the vials arrive with third-party certificates of analysis, which is the minimum documentation worth accepting on anything intended for injection.
Why This Particular Pairing
Growth hormone release is governed by more than one input. GHRH from the hypothalamus tells the pituitary to release. Ghrelin from the gut amplifies that release and blunts somatostatin, the brake. Push both levers at once and the output is larger than pushing either alone. This synergy between GHRH analogues and ghrelin receptor agonists is one of the better established findings in pituitary physiology, and it is the entire pharmacological argument for the stack.
The choice of the no-DAC version is also deliberate. The long-acting DAC form keeps GHRH signalling elevated for most of a week, which produces sustained IGF-1 but flattens the natural pulse pattern. The short-acting version's timing lines up with ipamorelin's, which makes co-administration straightforward and keeps release pulsatile.
FIT Stack Review of the Reported Protocol
These are figures from research contexts, not an approved label. There is no established human therapeutic dose for either compound.
| Parameter | CJC-1295 no DAC | Ipamorelin |
|---|---|---|
| Reported dose per injection | 100 to 200 mcg | 100 to 200 mcg |
| Frequency | 1 to 3 times daily | 2 to 3 times daily |
| Usual timing | Fasted morning, post-exercise, pre-sleep | Same, co-administered |
| Reconstitution | Bacteriostatic water, refrigerate after | Same |
| Reported cycle length | 8 to 16 weeks, then a break | Same |
Two practical points that get skipped. Food, particularly fat and carbohydrate, blunts the growth hormone response, which is why doses are timed away from meals. And the pre-sleep dose is the one that matters most in theory, because the largest natural growth hormone pulse happens in slow wave sleep and the compound is meant to sit alongside it rather than replace it.
A Realistic Results Timeline
This is where most reviews of this stack overreach. What follows is what users consistently describe, labelled as such, with a note on what has actually been measured.
| Period | What people commonly report | What the evidence supports |
|---|---|---|
| Weeks 1 to 2 | Deeper sleep, more vivid dreams, some water retention | Growth hormone release is measurable and rapid. Sleep effects are subjective and unblinded |
| Weeks 3 to 4 | Faster recovery between training sessions | IGF-1 rises measurably. Recovery improvement is self-reported |
| Weeks 6 to 8 | Changes in how the body looks and feels, some report reduced abdominal fat | No adequately sized human trial has tested body composition endpoints for this combination |
| Weeks 12 to 16 | Skin and joint changes reported anecdotally | Not established |
Two things are worth saying plainly. First, sleep quality is the effect people report most consistently and earliest, and it is also the one most vulnerable to expectation, since anyone injecting a growth hormone peptide before bed is primed to notice their sleep. Second, the step from "growth hormone and IGF-1 went up" to "body composition changed" is an assumption, not a result. Growth hormone rising is a measurement. Fat loss and lean mass gain are claims that would need controlled trials, and in this class those trials do not exist at any useful scale.
Anyone whose training and diet also change during a 12 week block will have no way of separating the compound's contribution from everything else.
What It Costs and Whether the Bundle Saves Anything
Ascension Peptides sells the two vials individually as well as bundled. At the time of writing the bundle price sits close to what the vials cost bought separately, so the argument for it is convenience and consistent batch documentation rather than a meaningful discount. Prices in this market move, so check the current figures rather than trusting any number printed in an article.
Bacteriostatic water is a separate small cost, and it is not optional. See our guides to buying the FIT stack and the broader FIT stack peptide guide for more detail.
Side Effects Worth Knowing About
The combination does not create new side effects. It increases exposure to the ones both compounds already produce through growth hormone.
- Flushing and warmth for up to half an hour after injection
- Water retention, more noticeable than with ipamorelin alone, mostly in weeks one to four
- Headache in the first fortnight
- Drowsiness after evening dosing, generally considered a benefit
- At higher exposures: joint stiffness and tingling in the hands, both fluid-related and both dose dependent
Anyone with an active cancer diagnosis, diabetic retinopathy, or who is pregnant or breastfeeding should not use these compounds. Growth hormone opposes insulin, so people with insulin resistance or diabetes need medical input first. Both compounds are on the World Anti-Doping Agency prohibited list.
For a fuller breakdown, see our page on ipamorelin side effects and on whether ipamorelin is safe.
Who This Stack Suits, and Who It Does Not
It makes sense for someone who already understands that these are unapproved research compounds, who wants the cleanest option in a category full of messier ones, and who is prepared to run a defined block and then stop.
It makes no sense for anyone expecting a body composition result on the strength of the marketing, anyone in tested sport, anyone unwilling to handle reconstitution and sterile injection properly, or anyone hoping to skip the training and diet work that actually drives the outcomes being promised.
FAQ
Is the FIT Stack pre-mixed?
No. It is two separate vials of lyophilised powder, reconstituted individually. In practice the two are often drawn into one syringe for a single injection because their timing is compatible, but they arrive separate.
Why no DAC rather than CJC-1295 with DAC?
The no-DAC version clears in about half an hour, keeping growth hormone release pulsatile in the way normal physiology does, and its timing matches ipamorelin's. The DAC version's week-long half-life is more convenient but produces a continuous plateau and cannot be reversed once injected.
How long before anything is noticeable?
Sleep changes are what people describe first, usually within the first fortnight. Anything relating to body composition, if it happens at all, would be a matter of months and is confounded by everything else a person is doing.
Does the stack need to be cycled?
Reported protocols run eight to sixteen weeks and then break, on the reasoning that continuous stimulation reduces pituitary receptor sensitivity. That is convention rather than something settled by trial data, but the underlying receptor behaviour is real.
Can it be combined with other peptides?
People do combine it with recovery and longevity compounds. Every addition increases the number of variables and the number of unknowns, and nothing about combining unapproved compounds has been tested for safety. Adding more is not the same as doing more.
